Literature DB >> 23640208

Prognostic models: rising to the challenge.

Nicola McCarthy.   

Abstract

Mesh：

Year:  2013        PMID： 23640208     DOI： 10.1038/nrc3530

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  6 in total

1.  JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.

Authors:  Chris P Miller; Jason D Thorpe; Amanda N Kortum; Catherine M Coy; Wei-Yi Cheng; Tai-Hsien Ou Yang; Dimitris Anastassiou; J David Beatty; Nicole D Urban; C Anthony Blau
Journal:  Cancer Immunol Res       Date:  2014-01-15       Impact factor: 11.151

2.  Expression of FGD3 gene as prognostic factor in young breast cancer patients.

Authors:  Irene Renda; Simonetta Bianchi; Vania Vezzosi; Jacopo Nori; Ermanno Vanzi; Ketty Tavella; Tommaso Susini
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

3.  TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer.

Authors:  Xiao-Yi Xu; Wen-Jing Guo; Shi-Hua Pan; Ying Zhang; Feng-Lin Gao; Jiang-Tao Wang; Sheng Zhang; He-Ying Li; Ren Wang; Xiao Zhang
Journal:  Aging (Albany NY)       Date:  2020-10-08       Impact factor: 5.682

4.  JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer.

Authors:  Bo Chen; Jianguo Lai; Danian Dai; Rong Chen; Xuan Li; Ning Liao
Journal:  Aging (Albany NY)       Date:  2019-12-02       Impact factor: 5.682

5.  Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.

Authors:  Gaojianyong Wang; Dimitris Anastassiou
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

6.  Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.

Authors:  Kaiyi Zhu; Lingyi Cai; Chenqian Cui; Juan R de Los Toyos; Dimitris Anastassiou
Journal:  PLoS Comput Biol       Date:  2021-07-20       Impact factor: 4.475
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.